Jeff Ajer
2012
In 2012, Jeff Ajer earned a total compensation of $2.7M as Senior Vice President, Chief Commercial Officer at BioMarin Pharmaceutical.
Compensation breakdown
| Non-Equity Incentive Plan | $175,200 |
|---|---|
| Option Awards | $218,530 |
| Salary | $332,613 |
| Stock Awards | $1,925,192 |
| Other | $6,010 |
| Total | $2,657,545 |
Ajer received $1.9M in stock awards, accounting for 72% of the total pay in 2012.
Ajer also received $175.2K in non-equity incentive plan, $218.5K in option awards, $332.6K in salary and $6K in other compensation.
Rankings
In 2012, Jeff Ajer's compensation ranked 2,653rd out of 11,487 executives tracked by ExecPay. In other words, Ajer earned more than 76.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,653 out of 11,487 | 77th |
Division Manufacturing | 930 out of 4,252 | 78th |
Major group Chemicals And Allied Products | 210 out of 1,200 | 83rd |
Industry group Drugs | 123 out of 922 | 87th |
Industry Pharmaceutical Preparations | 100 out of 697 | 86th |
Source: SEC filing on April 23, 2015.
Ajer's colleagues
We found four more compensation records of executives who worked with Jeff Ajer at BioMarin Pharmaceutical in 2012.
2012
Daniel Spiegelman
BioMarin Pharmaceutical
Chief Financial Officer
2012
Jean-Jacques Bienaim
BioMarin Pharmaceutical
Chief Executive Officer
2012
Henry Fuchs
BioMarin Pharmaceutical
Chief Medical Officer
2012
Robert Baffi
BioMarin Pharmaceutical
Executive Vice President, Technical Operations
News
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2021 pay rises 1% to $18M
April 12, 2022
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2020 pay slips 2% to $18M
April 13, 2021
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2019 pay rises 18% to $18M
April 14, 2020
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2018 pay slips 2% to $16M
April 23, 2019